Brief: Cabaletta Bio Reports Third Quarter 2021 Financial Results And Provides Business Update
01/11/2021 11:16
Nov 1 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* QTRLY LOSS PER SHARE $0.45
* Q3 EARNINGS PER SHARE VIEW $-0.50 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3XZS5n
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cabaletta Bio
See all newsCabaletta Bio Q1 net loss widens as R&D costs rise
Brief: First Patients Dosed With Cabaletta Bio’S Rese-Cel Manufactured On Cellares' Automated Cell Shuttle™ Platform
Brief: IND Amendment Clearance Obtained For Clinical Manufacturing Of Rese-Cel From Cabaletta Bio Using Cellares' Automated Platforms
Cabaletta Bio reports smaller-than-expected Q3 loss
U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity